Moderna Inc.

NASDAQ: MRNA · Real-Time Price · USD
28.15
0.13 (0.46%)
At close: Aug 18, 2025, 3:00 PM

Moderna Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-3.56B -4.71B 8.36B 12.2B
Depreciation & Amortization
189M 621M 348M 232M
Stock-Based Compensation
429M 305M 226M 142M
Other Working Capital
-626M -1.39B -5.98B 4.28B
Other Non-Cash Items
17M -19M 59M 54M
Deferred Income Tax
n/a 828M -559M -318M
Change in Working Capital
-78M -139M -3.46B 1.31B
Operating Cash Flow
-3B -3.12B 4.98B 13.62B
Capital Expenditures
-1.05B -707M -400M -284M
Cash Acquisitions
n/a -85M n/a n/a
Purchase of Investments
-6.53B -3.78B -11.44B -12.65B
Sales Maturities Of Investments
9.53B 8.78B 6.7B 4.44B
Other Investing Acitivies
n/a n/a -40M -30M
Investing Cash Flow
1.95B 4.21B -5.18B -8.52B
Debt Repayment
-10M -270M -184M -140M
Common Stock Repurchased
n/a -1.15B -3.33B -857M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
56M -1.38B -3.45B -873M
Net Cash Flow
-999M -289M -3.64B 4.22B
Free Cash Flow
-4.05B -3.83B 4.58B 13.34B